Log into your Newser account
Joined Newser on:
Find what you're looking for
More about Newser:
Want to contribute?
Suggest a Story
Get our apps:
Install our app:
Stories 1 - 20 |
Bill to Cap Insulin Prices
Hinges on 10 GOP Votes
Apr 1, 2022 9:30 AM CDT
Bill to Cap Insulin Prices Hinges on 10 GOP Votes
Measure clears the House, but prospects uncertain in the Senate
- The House has passed a bill capping the monthly cost of insulin at $35 for insured patients, part of an election-year push by Democrats for price curbs on prescription drugs at a time of rising inflation, per the AP . Experts say the legislation, which passed 232-193 Thursday, would provide significant...
For This Popular Diabetes
Drug, a 'Surprisingly High' Risk
Mar 29, 2022 1:20 PM CDT
For This Popular Diabetes Drug, a 'Surprisingly High' Risk
Study: Offspring of men who filled metformin Rx during sperm development see risk of rare genital defects
- One of the most widely prescribed diabetes drugs has been linked to an increased risk of birth defects in the offspring of men who filled a prescription for it shortly before conception, according to new research. "When I saw the paper ... I thought: 'Yup, this is gonna go...
a Revolution in
Jun 29, 2021 12:00 PM CDT
Walmart Touts a Revolution in Diabetes Care
Retailer to offer low-cost analog insulin starting this week
- Walmart says diabetes patients can save up to 75% on rapid-acting insulin by purchasing its own brand of the drug, launching this week. What it calls the "first-ever private brand analog insulin"—to be sold at Walmart pharmacies this week and at Sam's Club pharmacies in mid-July—...
FDA Advisers Quit
Jun 10, 2021 9:25 AM CDT
FDA Advisers Quit Over Alzheimer's Drug: 'Sham Process'
They're not happy the agency OK'd Biogen's Aduhelm against panel's recommendation
- The week kicked off with controversy swirling around aducanumab, the drug being marketed by Biogen as Aduhelm to treat Alzheimer's disease. The drama continues, with two members of an advisory panel to the Food and Drug Administration stepping down over the agency's decision to OK the drug against...
FDA Approves Controversial
New Alzheimer's Drug
Jun 7, 2021 10:30 AM CDT
FDA Approves Controversial New Alzheimer's Drug
Biogen's aducanumab receives green light, despite questions about effectiveness
- Big news in the world of Alzheimer's: The FDA on Monday approved the first new treatment in nearly 20 years, disregarding warnings from independent advisers that the drug hasn't been shown to help slow the brain-destroying disease, per the AP . The drug aducanumab is made by Biogen and...
2 More Dings Against Drug:
an FDA Warning and a Study
Apr 24, 2020 11:44 AM CDT
2 More Dings Against Drug: an FDA Warning and a Study
Agency cautions hydroxychloroquine should only be used in very restricted settings
- The drug once touted by President Trump as a possible "game changer" in the fight against the coronavirus has been the subject of more sobering headlines of late, and the newest one from the Food and Drug Administration doesn't help matters. Per Stat News , the FDA on Friday...
Trump Called It a Potential
'Game Changer.' No Longer
Apr 22, 2020 11:55 AM CDT
Trump Called It a Potential 'Game Changer.' No Longer
A coronavirus panel recommended against hydroxychloroquine's use on Tuesday
- The bloom appears to be off the rose when it comes to the malaria drug hydroxychloroquine. President Trump has repeatedly touted it as a possible treatment for the novel coronavirus, but a yet-to-be-peer-reviewed study released Tuesday found there were more deaths among COVID-19 patients at US veteran hospitals who were...
Nov 1, 2019 12:33 PM CDT
Test Reveals Saoirse Kennedy Hill's Cause of Death
It was an accidental OD from alcohol, methadone, prescription drugs
- The autopsy for Saoirse Kennedy Hill in August didn't offer much insight into how she died, but now the toxicology tests are in: The death certificate for the 22-year-old notes she suffered an accidental overdose from a lethal mix of alcohol, methadone, and prescription drugs, per WCVB . Besides the...
Trump Administration Makes
Big Move on Pharmaceuticals
Jul 31, 2019 10:00 AM CDT
Trump Administration Makes Big Move on Pharmaceuticals
Americans will be allowed to import lower-cost prescription drugs from Canada
- The Trump administration said Wednesday it will set up a system to allow Americans to legally import lower-cost prescription drugs from Canada, weakening a long-standing ban that had stood as a top priority for the politically powerful pharmaceutical industry. Health and Human Services Secretary Alex Azar made the announcement Wednesday...
AG: Fake Pharmacist Doled
Out 750K Prescriptions
Jul 31, 2019 8:39 AM CDT
AG: Fake Pharmacist Doled Out 750K Prescriptions
For over 10 years, Kim Thien Le worked as Bay Area pharmacist without license: Xavier Becerra
- For more than 10 years, Kim Thien Le handed out scads of prescriptions as a pharmacist at a handful of Walgreens stores in the Bay Area—nearly 750,000 scripts when all was said and done, California Attorney General Xavier Becerra noted Tuesday. The problem, per the AG's statement:...
Opioid Crisis Sees Ray of Hope
May 11, 2019 1:40 PM CDT
Opioid Crisis Sees Ray of Hope
Use of prescription opioids actually fell in 2018
- For those grieving the opioid crisis, a sliver of hope: America's use of prescription opioids fell more than ever last year amid a government crackdown on drugmakers and pharmacists, CNBC reports. Overall use dropped 17% in 2018, the biggest decline on record, according to the health research firm IQVIA...
Amid Increasing Drug Recalls,
FDA Focuses on 2 Factories
Jan 15, 2019 8:00 AM CST
Amid Increasing Drug Recalls, FDA Focuses on 2 Factories
Agency: Factories in China, India that made blood pressure drugs have equipment, process problems
- With the significant number of drugs and drug ingredients made overseas, it's hard for the FDA to provide airtight oversight. But two plants in China and India that pump out oft-prescribed blood pressure and heart medications are now on the agency's radar after FDA tests revealed trace amounts...
Prescription Was Just One
Letter Off, but ... Oh Man
Jan 8, 2019 4:32 PM CST
Prescription Was Just One Letter Off, but ... Oh Man
Woman given ED cream for her eyes, prompting call for use of block letters by doctors
- A woman in Scotland went to the doctor with a dry eye condition and left with a prescription for a lubricant called VitA-POS. All good so far. The pharmacist, however, read the doctor's writing as Vitaros, which, while just one letter different, happens to be a cream used to...
Insurer's Drug Plan: We'll
Pay You to Go to Mexico
Oct 29, 2018 8:21 AM CDT
Insurer's Drug Plan: We'll Pay You to Go to Mexico
Workers in Utah get cash incentive to buy cheaper drugs across the border
- It's no secret that many prescription drugs are cheaper in Mexico than in the US—stories about "medical tourism" have been around for years, like this one in
. Now, however, a large health insurer in Utah has employed a novel approach to take advantage of the...
Trump Unveils Plan
to Lower Drug Prices
Oct 25, 2018 4:52 PM CDT
Trump Unveils Plan to Lower Drug Prices
It would apply to drugs administered at doctors' offices
- Less than two weeks before the midterm elections, in which health care has been a major issue, President Donald Trump on Thursday announced a plan to lower prices for some prescription drugs, the AP reports, saying it would stop unfair practices that force Americans to pay higher prices than people...
Amazon Just Made a Big Move
That Might Worry CVS
Jun 28, 2018 10:25 AM CDT
Amazon Just Made a Big Move That Might Worry CVS
Jeff Bezos is buying PillPack, an online pharmacy that dispenses prescription drugs
- There's a reason shares of CVS, Walgreens, and Rite Aid were tumbling Thursday, and it can be summed up in one word: Amazon. The retailing behemoth made its first significant move into the pharmacy business by buying PillPack, an online company that ships medications to customers' homes, reports the...
Company Sold $1.3B of a Drug
That's Not Hugely Effective
Jun 25, 2018 8:41 AM CDT
Company Sold $1.3B of a Drug That's Not Hugely Effective
Inside New York state's pushback against Orkambi
- Only 28,000 of the planet's 7 billion people are eligible to take the cystic fibrosis drug Orkambi. And yet that tiny population enabled drugmaker Vertex to make roughly $1.3 billion in sales off the product. How does that math work out? The annual price of the drug...
'Right-to-Try' Drug Bill
May 23, 2018 12:03 AM CDT
Congress Passes 'Right-to-Try' Drug Bill
Law will let terminally ill patients bypass FDA
- A "right-to-try" bill that allows terminally ill patients to request medication that hasn't been approved by the Food and Drug Administration has passed Congress and is expected to be signed by President Trump. The bill, which passed the Senate last August, sailed through the House Tuesday with a...
FDA Approves Potential
May 18, 2018 8:56 AM CDT
FDA Approves Potential Migraine Game-Changer
Monthly injection reduces migraine frequency without major side effects
- "Progress, but not a panacea." So proclaims an editorial in journal
on Aimovig, a first-of-its-kind drug purported to prevent chronic migraines without many side effects that was on Thursday approved by the FDA. The drug from Amgen and Novartis, and similar ones in their final stages, "...
Want Cheaper Prescriptions?
Don't Always Use Insurance
Mar 14, 2018 5:02 PM CDT
Want Cheaper Prescriptions? Don't Always Use Insurance
Study finds drugs often cheaper than insurance co-pays
- Having health insurance means saving money on prescriptions, right? Not necessarily. A study published Tuesday in
found insurance co-pays for generic drugs were actually higher than the cost of the drug 28% of the time. For name-brand drugs, it was 6%. Say your insurance has a $10 co-pay for...
Stories 1 - 20 |
Popular on Newser
Law & Order Actress Drowns in NY River
Cops: Subway Worker Killed Over Mayo Complaint
Witness at Surprise Jan. 6 Hearing Is Revealed
Jan. 6 Panel Calls Surprise Hearing
California's Biggest Landowner Closes Forests to Public
On This Day:
10 Years of Headlines
We see that you're using an ad-blocker.
To read our stories, you'll need to
turn off your ad-blocker.
As an advertising-supported site,
Newser can't exist without ads.
Turn off your ad-blocker
(for Newser only)
One last step.
You have to do this part yourself.
But you're a smartie, and we'll help you out.
1. Click on your ad-blocker icon in your browser.
(It might look like this
2. Every ad-blocker is a bit different, but look for
an option like disable, whitelist, or trust and click it.
Thanks so much.